Myriad Genetics(GB:0K3W)
$5.62-0.24 (-4.10%)
GB:0K3W
Myriad Genetics ownership
$5.62
At close:-0.24 (-4.10%)
Myriad Genetics (0K3W) Ownership - Who Owns Myriad Genetics?
0 Followers
Myriad Genetics (0K3W) Ownership Overview
- 5.71% Insiders
- 18.24% Mutual Funds
- 19.00% Other Institutional Investors
- 17.18% ETFs
- 39.86% Public Companies and Individual Investors
The ownership structure of Myriad Genetics (GB:0K3W) stock is a mix of institutional, retail, and individual investors. Approximately 54.43% of the company’s stock is owned by Institutional Investors, 5.71% is owned by Insiders, and 39.86% is owned by Public Companies and Individual Investors.
The ownership structure of Myriad Genetics (GB:0K3W) stock is a mix of institutional, retail, and individual investors. Approximately 54.43% of the company’s stock is owned by Institutional Investors, 5.71% is owned by Insiders, and 39.86% is owned by Public Companies and Individual Investors.
Recent Insider Trading Activity
| Date | Name | Activity | Value |
|---|---|---|---|
| May 13, 2026 | Paul Bisaro | $27,600 | |
| Mar 08, 2026 | Samraat S. Raha | $199,600 | |
| Feb 26, 2026 | Louise Phanstiel | $494,487 |
Recent Hedge Fund Trading Activity
| Date | Firm | Activity | Value |
|---|---|---|---|
| Dec 31, 2025 | Graham Capital Management, L.p. | $185,096 | |
| Dec 31, 2025 | Royce & Associates Llc | $3,720,750 | |
| Dec 31, 2025 | Fisher Asset Management Llc | $7,423,166 |
Top Shareholders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| BlackRock, Inc. | 15,924,022 | Institution | 16.60% | 89,493,004 |
| Larry Robbins | 5,411,978 | Institution | 5.64% | 30,415,316 |
| Vanguard | 5,102,517 | Institution | 5.32% | 28,676,146 |
| Ishares | 4,489,002 | Institution | 4.68% | 25,228,191 |
| Vanguard Index Funds | 3,990,763 | Institution | 4.16% | 22,428,088 |
| Spdr | 3,294,226 | Institution | 3.43% | 18,513,550 |
| Tiaa-cref Funds | 1,966,783 | Institution | 2.05% | 11,053,320 |
| Blackrock Funds | 1,892,092 | Institution | 1.97% | 10,633,557 |
| Vanguard Horizon Funds | 1,704,409 | Institution | 1.78% | 9,578,779 |
| Ken Fisher | 1,190,896 | Institution | 1.24% | 6,692,836 |
Top Mutual Fund Holders
| Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| Vanguard Index Funds | 3,990,763 | Institution | 4.16% | 22,428,088 |
| Tiaa-cref Funds | 1,966,783 | Institution | 2.05% | 11,053,320 |
| Blackrock Funds | 1,892,092 | Institution | 1.97% | 10,633,557 |
| Vanguard Horizon Funds | 1,704,409 | Institution | 1.78% | 9,578,779 |
| Fidelity Salem Street Trust | 1,152,201 | Institution | 1.20% | 6,475,370 |
| Federated Hermes Mdt Series | 1,116,258 | Institution | 1.16% | 6,273,370 |
| Fidelity Concord Street Trust | 891,494 | Institution | 0.93% | 5,010,196 |
| Schwab Capital Trust | 851,143 | Institution | 0.89% | 4,783,424 |
| Vanguard Scottsdale Funds | 623,795 | Institution | 0.65% | 3,505,728 |
| Goldman Sachs Trust | 441,159 | Institution | 0.46% | 2,479,314 |
FAQ
Who Owns Myriad Genetics (GB:0K3W)?
According to the latest TipRanks data, approximately 54.43% of the company's stock is held by institutional investors, 5.71% is held by insiders, and 39.86% is held by public companies and individual investors.
What percentage of Myriad Genetics (GB:0K3W) stock is held by institutional investors?
According to the latest TipRanks data, approximately 54.43% of Myriad Genetics (GB:0K3W) stock is held by institutional investors: 18.24% by mutual funds, 17.18% by ETFs and 19.00% by other institutional investors.
What percentage of Myriad Genetics (GB:0K3W) stock is held by retail investors?
According to the latest TipRanks data, approximately 39.86% of Myriad Genetics (GB:0K3W) stock is held by public companies and individual investors.
Who owns the most shares of Myriad Genetics (GB:0K3W)?
BlackRock, Inc. owns the most shares of Myriad Genetics (GB:0K3W).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
